Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 4,507 shares at $4.82 ($22K) on 2021-08-03, disclosed to the SEC on 2021-08-03.
Seasonal sale ($22k) by See Remarks — this insider has traded CLVS in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.82 | 2,034 | $10K | 45.1% |
| 2 | $4.82 | 2,473 | $12K | 54.9% |
| Total | $4.82 avg | 4,507 | $22K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |